MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

23 May 2026 Evaluate
The March 2026 quarter revenue stood at Rs. 703.00 millions, up 15.82% as compared to Rs. 607.00 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 572.00 millions  from Rs. 9.00 millions in the quarter ended March 2026.Operating profit surged to 150.00 millions from the corresponding previous quarter of 112.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 703.00 607.00 15.82 2635.00 2314.00 13.87 2635.00 2314.00 13.87
Other Income 5.00 3.00 66.67 24.00 202.00 -88.12 24.00 202.00 -88.12
PBIDT 150.00 112.00 33.93 512.00 609.00 -15.93 512.00 609.00 -15.93
Interest 9.00 31.00 -70.97 73.00 129.00 -43.41 73.00 129.00 -43.41
PBDT 54.00 81.00 -33.33 352.00 480.00 -26.67 352.00 480.00 -26.67
Depreciation 13.00 15.00 -13.33 60.00 66.00 -9.09 60.00 66.00 -9.09
PBT 41.00 66.00 -37.88 292.00 414.00 -29.47 292.00 414.00 -29.47
TAX -531.00 57.00 -1031.58 93.00 192.00 -51.56 93.00 192.00 -51.56
Deferred Tax -533.00 7.00 -7714.29 47.00 -13.00 -461.54 47.00 -13.00 -461.54
PAT 572.00 9.00 6255.56 199.00 222.00 -10.36 199.00 222.00 -10.36
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 21.34 18.45 15.64 19.43 26.32 -26.17 19.43 26.32 -26.17
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..